Build
CJC-1295 6mg + Ipamorelin 12mg
The full picture
What Build is — in plain English.
An educational overview: what it is, what people use it for, how it works, and who it is not for. This is not a grade or a claim of effectiveness.
What's in it
| PEPTIDE | DOSE | ROLE IN THIS BLEND |
|---|---|---|
| CJC-1295 | 6mg | Ignites the pathway — establishes a sustained baseline signal telling the pituitary to release growth hormone. |
| Ipamorelin | 12mg | Delivers a clean pulse on top of that baseline — cortisol-neutral, without the broader hormonal disturbance older secretagogues cause. |
The combination logic
CJC-1295 sets up a steady, longer-lasting signal telling the pituitary to release growth hormone. Ipamorelin adds a clean, sharp pulse on top of that signal, without raising cortisol or other hormones the way older growth-hormone peptides can. Together they’re meant to produce a release pattern closer to what the body does naturally than either one alone. Clinical detail: CJC-1295 is a GHRH analog that establishes sustained GHRH-receptor signaling at the pituitary. Ipamorelin is a selective ghrelin-receptor (GHS-R) agonist that delivers a cortisol-and prolactin-neutral GH pulse. Because the two act on different receptors in the same pathway, their combined effect is proposed to be synergistic — GHRH signaling amplifying the pituitary’s responsiveness to the GHRP pulse — producing a more pronounced and more naturally patterned GH release than either compound alone.
Is there evidence for the combination, or only for the parts? CJC-1295 and Ipamorelin each have limited human data individually, and neither is FDA-approved for any indication. The combination itself has not been tested in a controlled human trial — the rationale for pairing them (complementary receptor mechanisms) is mechanistic, not the product of comparative research. This is one of the more commonly used combinations in compounded peptide therapy, which speaks to clinical popularity, not to proven superiority over either peptide alone.
What it's used for
| USED FOR | IN SHORT |
|---|---|
| Sleep quality and overnight recovery | A commonly cited rationale for this pairing, tied to growth hormone’s natural nighttime release pattern. |
| Lean tissue support and recovery | The combination is intended to mirror the body’s own pulsatile GH release more closely than either peptide alone. |
| Foundational GH support | Frequently used as a base pairing that other peptides are added to for more targeted goals. |
Overlaps & stacked risks
- Combined GH-axis stimulation carries the summed risk profile of both peptides.
- Water retention, mild headache, and injection-site flushing are the most commonly reported effects.
- Long-term human safety data does not exist for either peptide individually, let alone in combination.
- Effects on insulin sensitivity should be monitored in patients with any glucose-metabolism history.
Who it is not for
- Pregnant or breastfeeding patients
- Anyone with active malignancy or a history of cancer without physician clearance
- Patients with uncontrolled diabetes or significant cardiovascular disease
- Competitive athletes subject to anti-doping testing — GH secretagogues are prohibited in-competition
Who it suits
Patients seeking foundational growth-hormone support — for recovery, sleep quality, or as a base for a more targeted protocol — who have no contraindicating history and have discussed the limited evidence base with their provider.
Who makes this, and under what rules
Everything dispensed here is prepared by a licensed 503A compounding pharmacy — not bought from a supplier and repackaged, and not sourced from an online seller. That designation carries specific, enforceable obligations:
- A prescription in your name. Compounded from a prescription for one identified patient, after an evaluation.
- Licensed and inspected. A state license, subject to inspection by the state board of pharmacy.
- Sterile preparation to a published standard. USP standards.
- A paper trail. A lot number and beyond-use date on every preparation.
A compounded preparation is not an FDA-approved medicine — but it is the difference between a licensed pharmacy working to a standard and an unregulated website. This page describes Build for general educational purposes. It is not medical advice and does not replace a consultation with a licensed provider. Individual results vary, and combination products carry the risks of each included peptide.
Products are available only by prescription after a consultation with a licensed provider, who decides whether treatment is appropriate. Many compounds described here are not FDA-approved medicines and have not been tested in people for the uses described; information on this site is educational and is not medical advice.